Polypharmacy and Clinically Significant Drug Interactions Among HIV-Infected Patients Receiving Antiretroviral Therapy

• Conditions: HIV

• Registration Number: NCT03123575
• Lead Sponsor: Hospital General Universitario Gregorio Marañon

Brief Summary

This will be a cross-sectional population-based study carried out in the region of Madrid (6,468,322 inhabitants according to current census) to quantify the number of Co-meds in HIV-infected individuals on ART in the region of Madrid, categorized by age and gender, and to compare the number of Co-meds between the ART-treated population and HIV-uninfected population in the region of Madrid, categorized by age and gender.

Detailed Description

This will be a cross-sectional population-based study carried out in the region of Madrid (6,468,322 inhabitants according to current census) to quantify the number of Co-meds in HIV-infected individuals on ART in the region of Madrid, categorized by age and gender, and to compare the number of Co-meds between the ART-treated population and HIV-uninfected population in the region of Madrid, categorized by age and gender.

Study Timeline

• Study First Submitted: 2017-04-17
• Study First Submitted QC: 2017-04-20
• Study First Posted: 2017-04-21
• Status Verified: 2017-06
• Study Start: 2017-06
• Last Update Submitted: 2017-06-08
• Last Update Posted: 2017-06-09
• Primary Completion: 2017-10
• Study Completion: 2017-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• patients who picked-up Co-meds in the study period

Exclusion Criteria

• NONE

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
the number of Co-meds in HIV-infected individuals on ART	6 months	number of Co-meds in HIV-infected individuals on ART in the region of Madrid, categorized by age and gender.
number of Co-meds between the ART-treated population and HIV-uninfected	6 months	the number of Co-meds between the ART-treated population and HIV-uninfected population in the region of Madrid, categorized by age and gender.
prevalence of potential CSDIs between ARVs and Co-meds in ART-treated individuals	6 months	prevalence of potential CSDIs between ARVs and Co-meds in ART-treated individuals, with description of the types of harm expected from each different potential CSDIs identified